Copyright
©The Author(s) 2023.
World J Gastroenterol. Sep 21, 2023; 29(35): 5154-5165
Published online Sep 21, 2023. doi: 10.3748/wjg.v29.i35.5154
Published online Sep 21, 2023. doi: 10.3748/wjg.v29.i35.5154
Table 2 Changes in the acute gastrointestinal injury grades of the patients in the two groups
| AGI I, n (%) | AGI II, n (%) | AGI III, n (%) | AGI IV, n (%) | |||||
| Control group | Intervention group | Control group | Intervention group | Control group | Intervention group | Control group | Intervention group | |
| Day 1 | 0 (0) | 0 (0) | 6 (12.50) | 6 (12.77) | 29 (60.42) | 29 (61.70) | 13 (27.08) | 12 (25.53) |
| Day 3 | 0 (0) | 0 (0) | 14 (29.17) | 20 (42.55) | 30 (62.50) | 26 (55.32) | 4 (8.33) | 1 (2.13) |
| Day 7 | 7 (14.58) | 17 (36.17) | 31 (64.58) | 28 (59.57) | 10 (20.83) | 2 (4.26) | 0 (0) | 0 (0) |
- Citation: Chen TT, Lv JJ, Chen L, Li M, Liu LP. Heparanase inhibition leads to improvement in patients with acute gastrointestinal injuries induced by sepsis. World J Gastroenterol 2023; 29(35): 5154-5165
- URL: https://www.wjgnet.com/1007-9327/full/v29/i35/5154.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i35.5154